FridayNov 05, 2021 10:52 am

German Cannabis Market Expected to Liberalize Post Election, RYAH Group Inc. (CSE: RYAH) Enters Germany Via Observational Study

German Social Democrat-led coalition expected to liberalize medical cannabis market  Analysts predict over one million medical cannabis patients in Germany by 2024, market estimated to reach $8.9 billion by 2028 RYAH entered German market via observational study with Four 20 Pharma GmbH RYAH provides IoT product ecosystem of volume-control devices, medicine-carrying components, mobile applications RYAH ecosystem offers reliable way for researchers and clinicians to develop well-controlled research environments Germany’s recent 2021 election is expected to result in a new political environment via a coalition containing cannabis-positive political factions that aim to liberalize the country’s plant-based medicine market (https://cnw.fm/z1BxY). RYAH Group…

Continue Reading

WednesdayNov 03, 2021 12:31 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences New Animal Study Evaluating Patented DehydraTECH(TM) Technology’s Efficacy in Reducing/Inhibiting Seizure Activity; Strengthens IP Portfolio

Lexaria recently announced the commencement of EPIL-A21-1, an animal study to evaluate whether DehydraTECH-CBD has similar or superior efficacy in reducing or inhibiting seizure activity compared to FDA-approved seizure drug, Epidiolex The study will also compare DehydraTECH-CBD to generic CBD EPIL-A21-1 has entered early-stage preparatory work, with results expected in Q3 2022 Lexaria received new patent awards in Mexico and Japan, strengthening its IP portfolio to 23 granted patents Lexaria Bioscience (NASDAQ: LEXX), the drug delivery platform innovator behind the disruptive, patented DehydraTECH(TM) technology, recently announced it had commenced an important new animal study, EPIL-A21-1 (https://cnw.fm/iMVe3). EPIL-A21-1, which will be…

Continue Reading

MondayNov 01, 2021 1:34 pm

Successful Ginkgo Bioworks SPAC IPO Highlights Available Industry Opportunities for InMed Pharmaceuticals Inc. (NASDAQ: INM) and Synthetic Cannabinoid Production

Special purpose acquisition company Soaring Eagle Acquisition Corp. combined with Ginkgo Bioworks to form publicly listed Ginkgo Bioworks Holdings Inc., in what is the largest-ever biotechnology go-public transaction Ginkgo Bioworks is known for its work in the commercial-scale production of a rare cannabinoid, CBG, for use in a multitude of industrial needs InMed uses multiple manufacturing approaches to synthetically produce rare cannabinoids, including CBC which is currently sold through its subsidiary BayMedica The success of the Ginkgo IPO suggests the marketplace value associated with the production of rare cannabinoids Special purpose acquisition company (“SPAC”) Soaring Eagle Acquisition Corp. (NASDAQ: SRNGU,…

Continue Reading

FridayOct 29, 2021 1:42 pm

Flora Growth (FLGC) Receives Global Medical Cannabis Certification, Launches New CBD Brand

Flora Growth Corp. is an international cannabis consumer packaged goods distributor and cultivator based in Colombia that has built an ecosystem that will support market-leading innovation within categories that matter most to consumers exploring plant-based consumer goods. The company recently obtained the Good Agricultural and Collection Practices (“GACP”) certification from international certification agency and global leader in medical cannabis certification Control Union Medical Cannabis Standard (“CUMCS”) Flora Growth also just announced the launch of a new brand named Munzhi that will initially provide 12 CBD products for wellness, hair, body, and face benefits Flora Growth’s Colombian operations are already producing…

Continue Reading

FridayOct 29, 2021 11:31 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Makes Strategic Additions to its Leadership; Completes Platinum Vape Management Transition

RWB appointed Chris Ecken as the new CFO effective October 2021 Ecken will lend over 25 years of experience from the alcohol beverage industry, helping RWB to shape sustainable long-term growth RWB also announced Colby De Zen’s appointment to its board of directors He will be integral to RWB’s move to close critical assets in Michigan and expedite expansions in Florida, California, Arizona, Illinois, Massachusetts and Oklahoma RWB also completed Platinum Vape LLC. (“PV”) management transition, with the addition of Shea Alderete, Joaquin Rodriguez and Craig Rosevear to its management RWB plans to bank on growing demand in Michigan and…

Continue Reading

TuesdayOct 26, 2021 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Addresses the Needs of Medical THC Users

Lexaria’s THC absorption animal study yielded promising results on the patented DehydraTECH(TM) technology It showed that the technology required a shorter time to deliver the same THC levels than concentration-matched controls Lexaria believes that through DehydraTECH, it is meeting the needs of medical THC users with its rapid delivery, increased overall THC delivery and high brain tissue delivery Lexaria Bioscience's (NASDAQ: LEXX) just-concluded oral tetrahydrocannabinol (“THC”) absorption animal study, THC-A21-1, yielded promising results on the effectiveness of the company’s patented DehydraTECH(TM) drug delivery technology. The study, performed by a leading, independent laboratory, involved 20 male Sprague Dawley rats split into…

Continue Reading

MondayOct 25, 2021 11:03 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Subsidiary Completes Development of Licensed Apopka Facility, Commences Cultivation Targeting Q4 Harvest

Red White & Bloom completed the build-out of its Apopka facility – phase one of a development strategy – and immediately commenced cultivation following the receipt of a cultivation license The initial licensed area is projected to generate annual revenue in excess of $10 million The Apopka facility will support phase two of the strategy, which entails the activation of thirty customized, self-contained growing pods Phase three will involve the activation of a 113,000 SF facility for cultivation located in Sanderson Upon closing the acquisition of an operational 45,000 square-foot greenhouse situated on 4.7 acres of land in Apopka, Florida…

Continue Reading

FridayOct 22, 2021 9:00 am

New Study Underscores Rapidity of Oral Drug Bio-delivery Using Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology as an Alternative to Smoking and Vaping

Oral drug delivery innovator Lexaria Bioscience is focused on providing alternatives to smoked or inhaled tobacco and cannabis products to help consumers reduce the threat to their lungs Lexaria’s patented technology — DehydraTECH(TM) — is a solution that processes active pharmaceutical ingredients into a powder or liquid form that can then be ingested with less harm than inhalation, while providing rapidity similar to inhalation substances DehydraTECH has previously shown the ability to move CBD into test subjects’ bloodstreams up to 20-fold higher than standard generic formulations New testing shows that DehydraTECH can similarly deliver THC to test subjects’ bloodstreams at…

Continue Reading

ThursdayOct 21, 2021 12:49 pm

Flora Growth Corp.’s (NASDAQ: FLGC) Leadership and Advisory Team Steering Company to Greater Heights

The growing cannabis industry is experiencing a rise in demand for experienced business executives to guide companies toward the top Flora Growth, which has achieved numerous milestones, is a testament to the importance of experienced leadership Established in 2019, Flora was the first all-outdoor cannabis cultivation company to list on NASDAQ and has the largest licensed cultivation footprint in Colombia The company also boasts the lowest production cost in the world of $0.06 per gram of dried flower Flora’s adherence to strict industry standards and prudent management of its finances positions it to become a global leader in the cannabis…

Continue Reading

WednesdayOct 20, 2021 9:39 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Inches Closer to Revolutionizing the Nicotine Industry with its Alternative Nicotine Delivery

Lexaria’s recent animal study on its patented DehydraTECH(TM) technology on nicotine absorption yielded ground-breaking results This study builds on an earlier 2018 study that demonstrated effective delivery of nicotine to the central nervous system in a rodent study The study’s success will serve as the foundation for a human trial that will compare the DehydraTECH-nicotine pouch performance to leading brands Zacks Small Cap Research recently did a deep dive on Lexaria Bioscience (NASDAQ: LEXX) and its contribution to alternative nicotine delivery. Its evaluation acknowledged that the global tobacco market is currently valued at $818 billion, mainly sustained by over 1.1…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977